IOVANCE BIOTHERAPEUTICS, INC. Income Statement
IOVA / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
IOVANCE BIOTHERAPEUTICS, INC. reported $264M in revenue and $391M in net loss for FY2025. Revenue has grown at a 1388.7% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $263.5M | $164.1M | $1.2M | - | - | - | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $173.2M | $93.2M | $1.0M | - | - | - | - | - | - | - | - | - | - | - | - |
| SG&A Expense | $152.3M | $152.3M | $106.1M | $104.1M | $83.7M | $60.2M | $40.8M | $28.4M | $21.3M | $26.7M | $12.4M | $8.2M | $3.8M | - | - |
| R&D Expense | $300.3M | $276.2M | $333.2M | $294.8M | $259.0M | $201.7M | $166.0M | $99.8M | $71.6M | $26.9M | $15.5M | $3.8M | $2.2M | $1.7M | $1.8M |
| Operating Income | -$403.4M | -$395.3M | -$460.6M | -$398.9M | -$342.7M | -$261.9M | -$206.9M | -$128.3M | -$92.9M | -$53.6M | -$27.9M | -$12.0M | -$22.6M | -$8.1M | -$21.2M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | $200.0K | -$5.7K | $444.7K | -$1.9M | $151.5K |
| Income Tax | -$2.1M | -$2.8M | -$3.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - |
| Net Income | -$391.0M | -$372.2M | -$444.0M | -$395.9M | -$342.3M | -$259.6M | -$197.6M | -$123.6M | -$92.1M | -$52.9M | -$27.7M | -$12.0M | -$25.4M | -$3.3M | -$25.7M |
| EPS (Basic) | -$1.09 | -$2.49 | -$2.23 | -$2.49 | -$2.23 | -$1.88 | -$1.59 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$1.09 | -$2.49 | -$2.23 | -$2.49 | -$2.23 | -$1.88 | -$1.59 | -$1.27 | -$1.41 | -$1.85 | -$0.62 | -$3.47 | -$4.14 | - | $0.00 |
| Shares Outstanding | 411.9M | 256.1M | 187.8M | 159.3K | 153.4K | 138.3K | 124.3K | 123.4M | 73.2M | 62.2M | 48.5M | 20.0M | 818.8K | 798.5K | 73.6M |
| Operating Margin | -153.1% | -240.9% | -38735.0% | - | - | - | - | - | - | - | - | - | - | - | - |
| Profit Margin | -148.4% | -226.8% | -37345.4% | - | - | - | - | - | - | - | - | - | - | - | - |